Catyalyst Pharmaceutical Partners (CPRX) Tops Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $31.37 --0%
Revenue Growth %: +5.9%
Financial Fact:
Loss from operations: -3.91M
Today's EPS Names:
PLCE, COE, JVA, More
Revenue Growth %: +5.9%
Financial Fact:
Loss from operations: -3.91M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Catyalyst Pharmaceutical Partners (NASDAQ: CPRX) reported Q2 EPS of ($0.05), $0.02 better than the analyst estimate of ($0.07).
For earnings history and earnings-related data on Catyalyst Pharmaceutical Partners (CPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nvidia pitches Vera CPU to Chinese clients with August delivery target
- Dollarama Inc. (DOL:CN) (DLMAF) PT Raised to Cdn$221 at BMO Capital
- Sharon AI surges premarket; New Oriental gains, Medline slips
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
